NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . October 13th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College - HIV drug maraviroc effective for drug-resistant patients

Sciele Pharma, Inc. - Sciele Pharma Announces That Plethora Solutions Has Completed European Phase III Trial of PSD502 for Premature Ejaculation

Cancer - Research from Royal Marsden Hospital yields new findings on cancer

Cancer Vaccines - Reports from Stanford University describe recent advances in cancer vaccines

Carcinoma - New research on carcinoma from T. Andre and co-authors summarized

Chemotherapy - New findings from L.J. Swinnen and co-authors describe advances in chemotherapy

Enzyme Research - Data on enzyme research published by researchers at University of Florence

Gastric Cancer - Reports from Odense University highlight recent research in gastric cancer

HIV/AIDS - New HIV/AIDS findings from S. Mehendale and co-researchers published

Life Sciences - Recent studies by R. Mehrotra and co-authors add new data to life sciences findings

Measles - Research from Mayo Clinic provides new data on measles

Non-Small Cell Lung Cancer - Report summarizes non-small cell lung cancer study findings from H. Kunitoh and co-researchers

Pancreatic Cancer - Researchers at University of Heidelberg publish new data on pancreatic cancer

Prostate Cancer - Research from M.K. Chadha and co-researchers provides new data on prostate cancer

Prostate Cancer - Research from University of Michigan in the area of prostate cancer described

Breast Cancer Therapy - City Hospital reports research in breast cancer therapy

Breast Cancer Therapy - Findings from Virginia Commonwealth University, Department of Radiation Oncology advance knowledge in breast cancer therapy

Cancer Therapy - Data on cancer therapy published by researchers at Northwestern University

Carcinoma Therapy - New carcinoma therapy findings from Institute of Oncology, Department of Radiation Oncology described

Chemotherapy - Research from Hospital de Pediatria provide new insights into chemotherapy in children

Chemotherapy - Research on chemotherapy in children discussed by scientists at Hospital de Pediatria

Clinical Trial Research - Researchers at Chinese Academy of Sciences target clinical trial research

HIV/AIDS Vaccines - Research reports from Fred Hutchinson Cancer Research Center provide new insights into HIV/AIDS vaccines

Melanoma Therapy - University of Schleswig-Holstein, Department of Dermatology details research in melanoma therapy

Prostate Cancer Therapy - New findings from Mount Vernon Hospital in the area of prostate cancer therapy published

A.P. Pharma, Inc. - A.P. Pharma Announces Positive Phase 3 Results with APF530 in the Prevention of CINV

Advinus Therapeutics P Ltd. - Advinus Therapeutics P Ltd. and Ortho-McNeil-Janssen Pharmaceuticals, Inc. Establish Drug Discovery and Development Collaboration

Aeolus Pharmaceuticals, Inc. - Aeolus Pharmaceuticals Announces Initiation of Multiple Dose Study of AEOL 10150 in a Patient with ALS

Allergies - Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology

APT Pharmaceuticals, Inc. - APT Pharmaceuticals Secures $32 Million in Series B Financing

Apthera, Inc. - Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer

Aptuit Inc. - Aptuit Launches Program to Accelerate Early Stage Drug Development

ArQule, Inc. - ArQule Achieves Clinical Milestone in MiT Trial with ARQ 197

Bipolar Disorder - Forest Laboratories, Inc. and Gedeon Richter Plc Announce Positive Phase II Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder

Bronchiectasis - ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia

Cempra Pharmaceuticals, Inc. - Cempra Pharmaceuticals and Biovista Enter Agreement for Macrolide Clinical Trial Design Support Studies

Clinical Trial Research - Critical Pharmaceuticals Enter Sustained Release hGH Arena

Clinical Trial Research - Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings

Columbia Laboratories, Inc. - Columbia Laboratories Reports Results from Phase II Clinical Trial of Vaginally-administered Lidocaine for Dysmenorrhea

Companies and Markets - Companies and Markets: "Innovative Clinical Trial Design and Management - Trends, success stories and impact upon research and development budgets" market report available now

Cystic Fibrosis - Transave, Inc. Secures $12.5 Million in New Financing

Drug Development - NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting

Emergent BioSolutions Inc. - Emergent BioSolutions Signs Contract with BARDA/NIAID, Valued at Up to $29.7 Million, to Fund Development of AV7909 - a Next Generation Anthrax Vaccine

Genentech, Inc. - Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy

Haemacure Corporation - Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors

Headache and Migraine - TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel

Heart Failure - Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure

Hollis-Eden Pharmaceuticals, Inc. - Hollis-Eden Pharmaceuticals Presents Additional Positive Findings for APOPTONE HE3235 in Preclinical Models of Castration-Resistant Prostate Cancer

Idera Pharmaceuticals, Inc. - Idera Pharmaceuticals Announces Preliminary Data from Phase 2a Clinical Study of IMO-2055 Monotherapy in Renal Cell Carcinoma

Neuropathic Pain - Pharmaleads' Lead Candidate for Pain, PL37, Enters Phase I

NewsRx - NewsRx Launches 19 New Technology Titles

OncoGenex Pharmaceuticals, Inc. - OncoGenex To Present At the BioContact Quebec 2008 Annual Conference

Ore Pharmaceuticals Inc. - Ore Pharmaceuticals Begins Clinical Trial of GL1001

PPD, Inc. - PPD Completes Acquisition of InnoPharm

Progenics Pharmaceuticals, Inc. - Progenics Announces Progress and Presentations in HIV Therapy Program

pSivida Corp. - pSivida Release: Results from the Six-Month Interim Readout of the Human PK Iluvien Study

Psoriasis - Synvista Therapeutics Receives Approval to Begin Phase 2 Trial of Topical SYI-2074 in Psoriasis

Telormedix SA - Telormedix Raises 21 Mio CHF in Series a Financing

Tranzyme Pharma - Tranzyme Pharma Announces Positive Phase IIb Results with Its Ghrelin Agonist, TZP-101, for Postoperative Ileus POI

VGX Pharmaceuticals - VGX Pharmaceuticals Awarded $23.5 Million NIH Contract to Develop DNA-Based Preventive HIV Vaccine Delivered Via Electroporation

VGX Pharmaceuticals - VGX Pharmaceuticals Commences Follow-on Phase I Study for Novel Oral Anti-Inflammatory Drug Targeting Rheumatoid Arthritis and Type 1 Diabetes

ViroStatics, srl - Virostatics' President and CEO, Dr. Franco Lori, to address the 2nd World Conference on Magic Bullets Ehrlich II in Nurnberg, Germany



Return to Top of Page

-----------------------
PR Login